Tradersnewsletters.com, a leading online financial newsletter source, Reports on the following Companies: IMD Companies, Inc. (OTCPINK:ICBU), Bourque Industries, Inc. (OTCPINK:BORK), Halberd Corporation (OTCPINK:HALB), Immunotech Laboratories, Inc. (OTCPINK:IMMB )

Every day we scan the markets for the hottest newsletters delivering the most gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.

Join Us Here: http://tradernewsletters.com/

IMD Companies, Inc. (OTCPINK:ICBU) announces that it has published the procedure for the issuance of Positive Solutions Inc. on the company's websites. All shareholders of record of ICBU stock on August 17, 2012, will receive one share of Positive stock for every two shares of ICBU stock held. The shares of Positive Solutions, a privately held Florida corporation, were issued to ICBU in exchange for the spin-off of the subsidiary last June. ICBU's Board of Directors approved a resolution to issue the shares on a one for two basis. Positive Solutions has been engaged in negotiations for potential acquisitions with various medical and non-medical companies as a platform to expand its activities in the industry, and is hopeful that a completed merger can be announced currently. "We are hopeful that these shares will represent a valuable asset not only for ICBU going forward, but for our shareholders that received the issuance as well," stated ICBU CEO Bruce Collette.

Keep up with the latest Hot Stock Picks for Free right here: http://tradernewsletters.com/

Bourque Industries, Inc. (OTCPINK:BORK), a development stage company in the process of commercializing its patented Kryron metal-alloying process using nanotechnology to fundamentally alter common metals at the molecular level to create ultra-high performing super alloys, announced this morning a restructuring and expansion of its Board of Directors and appointment of a new interim Chief Executive Officer. The Board of Directors was expanded from three to five seats, and an invitation to join the Board was extended to Matt Schissler and to Brent Willis. Mr. Schissler has already accepted the invitation, and the Board believes it likely that Mr. Willis will also accept. Sean Floyd was elevated to Chief Executive Officer, and John Bourque, the Founder of the Company and the inventor of its technology, was reposition as Chief Scientist.

Keep up with the latest Hot Stock Picks for Free right here: http://tradernewsletters.com/

Halberd Corporation (OTCPINK:HALB) has entered into an exclusive agreement with Unmanned Vehicle University (UVU). A cora-plast version of the Halberd Smoke Series(TM) Unmanned Aerial Vehicle (UAV) will be provided to each student in the Doctorate and Masters Degree programs in Unmanned Aircraft Systems Engineering and the Certificate in Unmanned Systems Project Management program. Halberd will be the exclusive provider to UVU's students who will use the UAV for research, engineering and pilot training. "This is an excellent addition to our world class institution that educates and trains future leaders in the commercial unmanned systems industry. This UAV will be integrated with several of our existing courses such as UAV Fundamentals, UAV Aerodynamics and UAV Test and Evaluation to give students important hands-on experience," says Dr. (Col. Ret.) Jerry LeMieux, UVU President.

Keep up with the latest Hot Stock Picks for Free right here: http://tradernewsletters.com/

Immunotech Laboratories, Inc. (OTCPINK:IMMB ) Immunotech Laboratories, Inc., today announced the appointment of Mr. Valentin Dimitrov to the company Board of Directors as Chief Financial Advisor effective immediately. Mr. Dimitrov (48) has an impressive professional history in the International Pharmaceutical World along with an impressive background in the formation and management of International Corporations, including the founding member and supervisory Board Chairman of the International Orthodox Bank - (present "Investbank" JSC). Immunotech Director Bo Linton, further commented Mr. Dimitrov has an extensive knowledge of the Immunotech "IPF" patented technology and has worked alongside the company for several years, assisting with International awareness and potential Clinical Trial progression for the company's Immunotherapy Treatments.

Keep up with the latest Hot Stock Picks for Free right here: http://tradernewsletters.com/

Find out where these companies are headed along with other active movers: http://tradernewsletters.com/

Disclosure: We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit http://tradernewsletters.com/ for complete risks and disclosures.

Contact:

info@tradernewsletters.com

www.tradernewsletters.com